Month: September 2019

Includes new non-motor, palliative care, and treatment advances A comprehensive new Canadian Guideline for Parkinson Disease, 2nd Edition, provides practical guidance for physicians, allied health professionals, people with Parkinson’s and families on disease management. CMAJ (Canadian Medical Association Journal www.cmaj.ca) published the new guideline accompanied by an easy-to-reference infographic and podcast. Parkinson’s is a debilitating, … Read more

The protein alpha-synuclein works its way into cells occupying parts of the brain affected by Parkinson’s disease as well as those cells in other parts of the brain that remain healthy. This observation has led researchers like Maxime Rousseaux at the University of Ottawa to consider whether this protein’s presence is harmful or helpful. The … Read more

At Laval University, PhD candidate Hélèna Denis is looking deep inside the blood cells of people with Parkinson’s disease. She is examining the connection between proteins linked to Parkinson’s and small pieces of cell membrane, called extracellular vesicles that can emerge from any cell. Her research is made possible through a Graduate Student Award from … Read more

Parkinson’s is the fastest growing neurological disease in the world. No matter at what age a person is diagnosed, receiving the news that you have Parkinson’s is frightening and life-changing. The average wait time to see a specialist for diagnosis of Parkinson’s in Canada is 11 months and in some regions the wait is 2+ … Read more